Jay Knight

Bass, Berry & Sims PLC

+ Follow Contact

Latest Posts › Board of Directors

Share:

FAQs on the SEC’s Newly Adopted Amendments to Rule 10b5-1 Trading Plans and Related Disclosures

We previously blogged here about the proposed Securities and Exchange Commission (SEC) amendments to Rule 10b5-1 trading plans. As the amendments have now been unanimously adopted, below are some answers to frequently asked...more

1/5/2023 / 10b5-1 Plans , Board of Directors , Corporate Counsel , Corporate Officers , Disclosure Requirements , Filing Requirements , Insider Trading , New Amendments , New Rules , Securities and Exchange Commission (SEC)

SEC Proposes Amendment to the Shareholder Proposals Rule (14a-8) and Adopts Amendments to Rules Impacting Proxy Advisory Firms

Last week, the Securities and Exchange Commission (SEC) voted 3-2 to take the following actions: Propose new amendments to Rule 14a-8, the shareholder proposal rule. Adopt new amendments to the rules regarding proxy...more

7/22/2022 / Board of Directors , Federal Register , Golden Parachutes , Proposed Amendments , Proxy Advisory Firms , Proxy Voting , Reporting Requirements , Securities and Exchange Commission (SEC) , Shareholder Proposals

SEC Staff Comments on Director Serving as Corporate Secretary

The rules of the New York Stock Exchange (NYSE) and the Nasdaq Stock Market (Nasdaq) require that a majority of a listed company’s board of directors (board) must be comprised of “independent directors” and that vital board...more

1/24/2022 / Board of Directors , Corporate Officers , Directors , Nasdaq , NYSE , Principal Executive Officer , Securities and Exchange Commission (SEC) , Securities Exchange Act

A Practical Guide to Evaluating a Company’s Defensive Profile

As public companies continue to navigate the ongoing economic upheaval caused by the COVID-19 pandemic, opportunistic activist investors may find the resulting economic conditions conducive to accumulating significant...more

7/27/2020 / Activist Investors , Board of Directors , Bylaws , Coronavirus/COVID-19 , Dilution , Documentation , Publicly-Traded Companies , Special Meetings , Written Consent

4 Results

View per page

Page: of 1